亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

A deep learning-based radiomic nomogram for prognosis and treatment decision in advanced nasopharyngeal carcinoma: A multicentre study

列线图 医学 鼻咽癌 肿瘤科 内科学 危险系数 阶段(地层学) 一致性 放射治疗 置信区间 生物 古生物学
作者
Lianzhen Zhong,Di Dong,Xueliang Fang,Fan Zhang,Ning Zhang,Liwen Zhang,Mengjie Fang,Wei Jiang,Shaobo Liang,Cong Li,Yujia Liu,Xun Zhao,Runnan Cao,Hong Shan,Zhenhua Hu,Jun Ma,Ling‐Long Tang,Jie Tian
出处
期刊:EBioMedicine [Elsevier BV]
卷期号:70: 103522-103522 被引量:108
标识
DOI:10.1016/j.ebiom.2021.103522
摘要

Induction chemotherapy (ICT) plus concurrent chemoradiotherapy (CCRT) and CCRT alone were the optional treatment regimens in locoregionally advanced nasopharyngeal carcinoma (NPC) patients. Currently, the choice of them remains equivocal in clinical practice. We aimed to develop a deep learning-based model for treatment decision in NPC.A total of 1872 patients with stage T3N1M0 NPC were enrolled from four Chinese centres and received either ICT+CCRT or CCRT. A nomogram was constructed for predicting the prognosis of patients with different treatment regimens using multi-task deep learning radiomics and pre-treatment MR images, based on which an optimal treatment regimen was recommended. Model performance was assessed by the concordance index (C-index) and the Kaplan-Meier estimator.The nomogram showed excellent prognostic ability for disease-free survival in both the CCRT (C-index range: 0.888-0.921) and ICT+CCRT (C-index range: 0.784-0.830) groups. According to the prognostic difference between treatments using the nomogram, patients were divided into the ICT-preferred and CCRT-preferred groups. In the ICT-preferred group, patients receiving ICT+CCRT exhibited prolonged survival over those receiving CCRT in the internal and external test cohorts (hazard ratio [HR]: 0.17, p<0.001 and 0.24, p=0.02); while the trend was opposite in the CCRT-preferred group (HR: 6.24, p<0.001 and 12.08, p<0.001). Similar results for treatment decision using the nomogram were obtained in different subgroups stratified by clinical factors and MR acquisition parameters.Our nomogram could predict the prognosis of T3N1M0 NPC patients with different treatment regimens and accordingly recommend an optimal treatment regimen, which may serve as a potential tool for promoting personalized treatment of NPC.National Key R&D Program of China, National Natural Science Foundation of China, Beijing Natural Science Foundation, Strategic Priority Research Program of CAS, Project of High-Level Talents Team Introduction in Zhuhai City, Beijing Natural Science Foundation, Beijing Nova Program, Youth Innovation Promotion Association CAS.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
36秒前
修辛完成签到 ,获得积分10
49秒前
LMY完成签到 ,获得积分10
55秒前
2分钟前
2分钟前
满意的梦竹完成签到,获得积分20
2分钟前
2分钟前
GingerF应助科研通管家采纳,获得50
2分钟前
GPTea应助科研通管家采纳,获得20
2分钟前
时光机带哥走完成签到 ,获得积分10
3分钟前
科研通AI5应助YuhengGuo采纳,获得10
3分钟前
JamesPei应助杜熙采纳,获得10
4分钟前
冬雪丶消融应助Desserts采纳,获得10
4分钟前
4分钟前
yf发布了新的文献求助10
4分钟前
汉堡包应助科研通管家采纳,获得10
4分钟前
4分钟前
JamesPei应助真实的依波采纳,获得10
5分钟前
麻花阳完成签到,获得积分10
5分钟前
5分钟前
YuhengGuo发布了新的文献求助10
5分钟前
yf发布了新的文献求助10
5分钟前
YuhengGuo完成签到,获得积分10
5分钟前
小蘑菇应助淡然的凡白采纳,获得10
5分钟前
6分钟前
6分钟前
6分钟前
6分钟前
领导范儿应助科研通管家采纳,获得10
6分钟前
小蘑菇应助矮小的猎豹采纳,获得10
6分钟前
李健应助矮小的猎豹采纳,获得10
6分钟前
共享精神应助温暖的夏波采纳,获得10
6分钟前
keyanbrant完成签到 ,获得积分10
6分钟前
种田完成签到,获得积分10
7分钟前
田様应助爱航哥多久了采纳,获得10
7分钟前
7分钟前
7分钟前
Criminology34应助科研通管家采纳,获得10
8分钟前
科研通AI6应助科研通管家采纳,获得10
8分钟前
彭于晏应助科研通管家采纳,获得10
8分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Einführung in die Rechtsphilosophie und Rechtstheorie der Gegenwart 1500
Binary Alloy Phase Diagrams, 2nd Edition 1000
Air Transportation A Global Management Perspective 9th Edition 700
DESIGN GUIDE FOR SHIPBOARD AIRBORNE NOISE CONTROL 600
NMR in Plants and Soils: New Developments in Time-domain NMR and Imaging 600
当代中国马克思主义问题意识研究 科学出版社 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4973920
求助须知:如何正确求助?哪些是违规求助? 4229267
关于积分的说明 13172382
捐赠科研通 4018238
什么是DOI,文献DOI怎么找? 2198802
邀请新用户注册赠送积分活动 1211395
关于科研通互助平台的介绍 1126508